
Vriglim-VG 1 Tablet SR
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Vriglim-VG 1 Tablet SR
Glycemic control medication, Diabetol-CX 1 SR tablet, is an anti-diabetic combination therapy for adult patients with type 2 diabetes. It helps regulate blood glucose. Diabetol-CX 1 SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular meals and carry a quick-acting glucose source, such as glucose tablets or juice. Alcohol increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your doctor of any history of heart disease before starting treatment; it may be unsuitable. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and blood tests to assess blood cell counts and liver function are necessary.
Primary Ingredients of Vriglim-VG 1 Tablet SR
There is no text provided to rephrase.
Uses of Vriglim-VG 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Vriglim-VG 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; refrain from chewing, crushing, or fracturing it. Administer Vriglim-VG 1 Tablet SR on an empty stomach.
Common Side effects of Vriglim-VG 1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vriglim-VG 1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; refrain from chewing, crushing, or fracturing it. Administer Vriglim-VG 1 Tablet SR on an empty stomach.
How Vriglim-VG 1 Tablet SR works:
Vriglim-VG 1 Extended-Release Tablet contains a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Vriglim-VG 1 Tablet SR is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Vriglim-VG 1 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Vriglim-VG 1 tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Vriglim-VG 1 Tablet SR in individuals with kidney impairment carries a significant risk and is best avoided. A physician's consultation is advised. Furthermore, its use is contraindicated for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Vriglim-VG 1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced starting dose is typically advised for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Vriglim-VG 1 Tablet SR :
Should you forget to take a Vriglim-VG 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vriglim-VG 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
